Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Sonoma Pharmaceuticals Q4 EPS $(0.48) Beats $(0.73) Estimate, Sales $3.75M Miss $4.44M Estimate

Author: Benzinga Newsdesk | June 17, 2025 03:12pm
Sonoma Pharmaceuticals (NASDAQ:SNOA) reported quarterly losses of $(0.48) per share which beat the analyst consensus estimate of $(0.73) by 34.25 percent. This is a 65.47 percent increase over losses of $(1.39) per share from the same period last year. The company reported quarterly sales of $3.75 million which missed the analyst consensus estimate of $4.44 million by 15.45 percent. This is a 9.16 percent increase over sales of $3.44 million the same period last year.

Posted In: SNOA


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist